Author:
Elgazzar Abdelhamid H.,Alenezi Saud
Publisher
Springer International Publishing
Reference10 articles.
1. Bouchelouche K, Turkbey B, Choyke PL (2016) PSMA PET and radionuclide therapy in prostate cancer. Semin Nucl Med 46(6):522–535.
https://doi.org/10.1053/j.semnuclmed.2016.07.006
. Epub 2016 Sep 3
2. Brans B, Bacher K, Vandevyver V, Vanlangenhove P, Smeets P, Thierens H, Dierckx RA et al (2003) Intra-arterial radionuclide therapy for liver tumors: effect of selectivity of catheterization and 131I-Lipiodol delivery on tumor uptake and response. Nucl Med Commun 24:391
3. Dash A, Das T, Knapp FFR (2019) Targeted radionuclide therapy of painful bone metastases: past developments, current status, recent advances and future directions. Curr Med Chem.
https://doi.org/10.2174/0929867326666190201142814
4. Elgazzar AH (2016) Therapeutic nuclear medicine. In: Elgazzar AH (ed) Pathophysiologic basis of nuclear medicine, 2nd edn. Springer, Berlin
5. Iagaru A, McDougall IR (2007) Treatment of thyrotoxicosis. J Nucl Med 48:379–389